NCT04109261View on ClinicalTrials.gov

Analysis of Palbociclib Treatment in Patients With Advanced Breast Cancer Within a Compassionate Use Programe

CompletedOBSERVATIONAL
Enrollment

237

Participants

Timeline

Start Date

September 18, 2018

Primary Completion Date

September 1, 2019

Study Completion Date

September 1, 2019

Conditions
Breast Cancer
Interventions
DRUG

Palbociclib

Palbociclib administration in breast cancer patients included in a compassionate use programme. Patients were treated according to the standard of care

Trial Locations (1)

28040

Fernando Moreno, Madrid

All Listed Sponsors
lead

Fernando Moreno Antón

OTHER

NCT04109261 - Analysis of Palbociclib Treatment in Patients With Advanced Breast Cancer Within a Compassionate Use Programe | Biotech Hunter | Biotech Hunter